首页> 外文期刊>Clinical neurology and neurosurgery >Comparative analysis of cerebrospinal fluid adenosine deaminase in tuberculous and non-tuberculous meningitis.
【24h】

Comparative analysis of cerebrospinal fluid adenosine deaminase in tuberculous and non-tuberculous meningitis.

机译:结核性和非结核性脑膜炎脑脊液腺苷脱氨酶的比较分析。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To calculate cut-off point for the adenosine deaminase (ADA) activity in the CSF of patients with tuberculous meningitis (TBM). PATIENTS AND METHODS: The ADA assay was based on the automatic indirect method in which ADA catalyzes adenosine to inosine. ADA activity in the CSF was calculated based on ammonia liberated from adenosine and quantified spectrophotometrically. Arithmetic mean values and standard deviation of each variable were measured. Mann-Whitney U and Fisher exact tests were applied to compare continuous and dichotomous variables between tuberculous and non-tuberculous groups. A receiver operating characteristic curve was plotted to identify various cut-off points to determine the best level for ADA activity. RESULTS: Totally 42 patients were enrolled into the study. The median of ADA activity in the TBM group was 22 and in the non-TBM group was 8.0. The mean CSF-ADA activity was found to be significantly higher in TBM group (23.05+/-13.1IU/L) than in the CSF from non-TBM patients (9.39+/-5.18IU/L). The highest accuracy is at the cut-off value of 10.5IU/L. The sensitivity and specificity of the test at this cut-off to differentiate TBM from non-tuberculous meningitis is 81% and 86% respectively. CONCLUSION: Considering that a high positive value of ADA activity cannot confirm TBM, however, in suspected patients it may lead the physician to treat patient earlier before the confirmatory diagnostic reports will be received. The suggested cut-off value in this pilot study is 10.5IU/L with high sensitivity and specificity.
机译:目的:计算结核性脑膜炎(TBM)患者脑脊液中腺苷脱氨酶(ADA)活性的临界点。患者与方法:ADA分析基于自动间接方法,其中ADA将腺苷催化为肌苷。 CSF中的ADA活性是根据从腺苷中释放出的氨水进行分光光度法计算的。测量每个变量的算术平均值和标准偏差。应用Mann-Whitney U和Fisher精确检验来比较结核病组和非结核病组之间的连续变量和二分变量。绘制接收机工作特性曲线以识别各种临界点,以确定ADA活动的最佳水平。结果:总共42例患者被纳入研究。 TBM组的ADA活性中位数为22,非TBM组的ADA活性中位数为8.0。发现TBM组的平均CSF-ADA活性(23.05 +/- 13.1IU / L)明显高于非TBM患者的CSF(9.39 +/- 5.18IU / L)。最高准确度为10.5IU / L的临界值。在该临界值时,区分TBM和非结核性脑膜炎的敏感性和特异性分别为81%和86%。结论:考虑到ADA活动的高阳性值不能确定TBM,但是,在怀疑的患者中,这可能会导致医生在收到确认性诊断报告之前更早地治疗患者。在该初步研究中,建议的临界值为10.5IU / L,具有较高的敏感性和特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号